| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.1M | +2.6% |
| Cost of Revenue | $1.4M | +14.1% |
| Gross Profit | $743K | -13.8% |
| R&D Expense | $3.1M | +59.1% |
| SG&A Expense | $4.3M | +14.3% |
| Operating Income | -$10.3M | -111.1% |
| Pre-tax Income | -$10.5M | -91.1% |
| Net Income | -$10.5M | -91.1% |
| EPS (Basic) | -$0.99 |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | +774.7% |
| Accounts Receivable | $74K | -50.3% |
| Inventory | $212K | +25.8% |
| Current Assets | $4.8M | +369.2% |
| Total Assets | $7.5M | -0.6% |
| Current Liabilities | $983K | -1.6% |
| Total Liabilities | $1.0M | -3.5% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.6M | -31.2% |
| Capital Expenditures | $92K | +77.8% |
| Investing Cash Flow | -$92K | -77.8% |
| Financing Cash Flow | $8.5M | +309.1% |
| Free Cash Flow | -$4.7M | -31.8% |
| -43.5% |
| EPS (Diluted) | -$0.99 | -43.5% |
| Stockholders' Equity |
| $6.4M |
| -0.1% |